TY  - JOUR
AU  - Lorscheider, Johannes
AU  - Jokubaitis, Vilija G
AU  - Spelman, Tim
AU  - Izquierdo, Guillermo
AU  - Lugaresi, Alessandra
AU  - Havrdova, Eva
AU  - Horakova, Dana
AU  - Trojano, Maria
AU  - Duquette, Pierre
AU  - Girard, Marc
AU  - Prat, Alexandre
AU  - Grand'Maison, François
AU  - Grammond, Pierre
AU  - Pucci, Eugenio
AU  - Boz, Cavit
AU  - Sola, Patrizia
AU  - Ferraro, Diana
AU  - Spitaleri, Daniele
AU  - Lechner-Scott, Jeanette
AU  - Terzi, Murat
AU  - Van Pesch, Vincent
AU  - Iuliano, Gerardo
AU  - Bergamaschi, Roberto
AU  - Ramo-Tello, Cristina
AU  - Granella, Franco
AU  - Oreja-Guevara, Celia
AU  - Butzkueven, Helmut
AU  - Kalincik, Tomas
AU  - MSBase Study Group
PY  - 2017
DO  - 10.1212/WNL.0000000000004330
UR  - http://hdl.handle.net/10668/11492
T2  - Neurology
AB  - To investigate the effect of disease-modifying treatment on short-term disability outcomes in secondary progressive multiple sclerosis (SPMS). Using MSBase, an international cohort study, we previously validated a highly accurate definition of SPMS....
LA  - en
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - Area Under Curve
KW  - Disability Evaluation
KW  - Disease Progression
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Longitudinal Studies
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Chronic Progressive
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Recurrence
KW  - Treatment Outcome
TI  - Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
TY  - research article
VL  - 89
ER  -